Circulating Proteomics Identifies a Dynamic Profile of Hepatic Steatosis During Metabolic Intervention

Background Weight reduction through lifestyle, activity, and dietary interventions are the mainstay of initial therapy for metabolic dysfunction associated steatotic liver disease. Data on the relative effectiveness and metabolic pathways linking weight loss and decreased hepatic steatosis are lacki...

Full description

Saved in:

Bibliographic Details
Main Authors:	Bassim El‐Sabawi, Kahraman Tanriverdi, Priya Gajjar, Matthew Nayor, Joshua M. Landman, Jennifer E. Below, Madeleine Haff, Michelle Long, Mark Ezpeleta, Jane E. Freedman, Krista Varady, Ravi Shah, Andrew S. Perry
Format:	Article
Language:	English
Published:	Wiley 2025-05-01
Series:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:	caloric restriction medical weight loss metabolic dysfunction associated steatotic liver disease nonalcoholic fatty liver disease proteomics
Online Access:	https://www.ahajournals.org/doi/10.1161/JAHA.124.037100
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Liver Stiffness, Not Steatosis, Predicts Mortality in MASLD Patients: An NHANES Analysis
by: Yuting Huang, et al.
Published: (2024-12-01)

Unmet needs of metabolic dysfunction – Associated “fatty or steatotic” liver disease
by: Yu-Ming Cheng, et al.
Published: (2025-04-01)

Metabolic Dysfunction–Associated Steatotic Liver Disease, Alcohol Consumption, and the Risk of Atrial Fibrillation: A Nationwide Population‐Based Study
by: Minkwan Kim, et al.
Published: (2025-07-01)

The impact of parity on the risk of nonalcoholic fatty liver disease defined by hepatic steatosis index: A nationwide cohort study
by: So-hyeon Hong, et al.
Published: (2025-07-01)

The impact of fasting on cardiovascular risk control in patients with metabolic dysfunction-associated steatotic liver disease
by: Anna E. Płatek, et al.
Published: (2023-09-01)

Age-specific protective effects of statins against cirrhosis in patients with chronic liver enzyme elevation associated with metabolic dysfunction: a retrospective cohort study of electronic health recordsResearch in context
by: Ayako Suzuki, et al.
Published: (2025-09-01)

FLI and FIB-4 in diagnosing metabolic dysfunction-associated steatotic liver disease in primary care: High prevalence and risk of significant disease
by: Mário Reis Álvares-da-Silva, et al.
Published: (2025-01-01)

The potential role of adipokines and hepatokines in age-related ocular diseases
by: Stavroula Almpanidou, et al.
Published: (2025-06-01)

Retinopathy in Metabolic Dysfunction-Associated Steatotic Liver Disease
by: Myrsini Orfanidou, et al.
Published: (2024-12-01)

Non-alcoholic fatty liver disease – a rapidly growing indication for liver transplantation in the modern world
by: I. M. Iljinsky, et al.
Published: (2019-10-01)

A bibliometric analysis of a decade’s research on metabolic dysfunction-associated steatotic liver disease in the Arab world
by: Waleed Alhazzani, et al.
Published: (2025-05-01)

Ultrasound Score of Liver Steatosis Severity in the Diagnosis of Peripheral Arterial Atherosclerosis in Patients with Nonalcoholic Fatty Liver Disease
by: A. S. Kuznetsova, et al.
Published: (2023-06-01)

Examining the prevalence of hepatic steatosis and advanced fibrosis using non-invasive measures across Canada: A national estimate using the Canadian Health Measures Survey (CHMS) from 2009-2019
by: Jacob Romano, et al.
Published: (2025-01-01)

Reproducibility of ultrasound-derived fat fraction in measuring hepatic steatosis
by: Danlei Song, et al.
Published: (2024-10-01)

In vitro antioxidant effects and in vivo hepatoprotective effects of Osbeckia octandra, Vernonia cinerea and Atalantia ceylanica on a high fat diet induced metabolic dysfunction-associated steatotic liver disease mouse model
by: Anuththara Upamali Abeykoon, et al.
Published: (2025-05-01)

Farnesoid X receptor (FXR) as a potential therapeutic target in nonalcoholic fatty liver disease and associated syndromes
by: Apollinariya V. Bogolyubova, et al.
Published: (2017-12-01)

Attenuation Based Quantitative Evaluation of Hepatic Steatosis Using US: Current Status and Future Perspective
by: Dong Ho Lee
Published: (2025-05-01)

Effect of Lactobacillus ramensus probiotic use and High Intensity Interval Training on the ratio of liver enzymes AST/ALT in desert mice with steatosis
by: Saeed Shahmohammadi, et al.
Published: (2023-10-01)

Mediation Analyses Link Cardiometabolic Factors and Liver Fat With White Matter Hyperintensities and Cognitive Performance: A UK Biobank Study
by: Daniel E. Askeland-Gjerde, et al.
Published: (2025-07-01)

Beyond Nonalcoholic Fatty Liver Disease: The Expansive Realm of Metabolic Dysfunction-associated Steatotic Liver Disease
by: Samir Samadarshi, et al.
Published: (2025-01-01)

Hyperinsulinemic male LEW.1WR1 rats show early signs of impaired liver metabolism
by: Madushika Wimalarathne, et al.
Published: (2025-03-01)

Chronic Inflammation and Immune Dysregulation in Metabolic-Dysfunction-Associated Steatotic Liver Disease Progression: From Steatosis to Hepatocellular Carcinoma
by: Young-Min Jee, et al.
Published: (2025-05-01)

Low-carbohydrate diets reduce cardiovascular risk factor levels in patients with metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis of randomized controlled trials
by: Shanshan Pi, et al.
Published: (2025-08-01)

Evaluation of Liver Fibrosis through Noninvasive Tests in Steatotic Liver Disease
by: Yuri Cho
Published: (2024-11-01)

Augmenter of Liver Regeneration Crotonylation Assists in Mitochondria-ER Contact to Alleviate Hepatic SteatosisSummary
by: Xiao-lin Wang, et al.
Published: (2025-01-01)

Clinical characteristics of lean metabolic-associated fatty liver disease and the impact of concurrent diabetes mellitus
by: Yu-Ming Cheng, et al.
Published: (2024-09-01)

Correspondence to letter to the editor 2 on “Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and risk of hepatocellular carcinoma: A nationwide cohort study”
by: Seogsong Jeong, et al.
Published: (2025-04-01)

Kaili sour soup in alleviation of hepatic steatosis in rats via lycopene route: an experimental study
by: Yi Li, et al.
Published: (2025-12-01)

Functional-morphological changes in non-alcoholic fatty liver disease after bariatric operations
by: Iu. I. Sedletskii, et al.
Published: (2019-02-01)

Diagnostic performance of FibroTouch® in assessing hepatic steatosis and fibrosis in patients with metabolic dysfunction-associated steatotic liver disease: An Asian experience
by: Thanikan Sukaram, et al.
Published: (2025-01-01)

The diagnostic value of MRI-PDFF in hepatic steatosis of patients with metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis
by: Yue-Xia Zhang, et al.
Published: (2025-07-01)

Association of uric acid levels with the development of metabolic dysfunction-associated and metabolic and alcohol-related/associated steatotic liver disease: a study on Japanese participants undergoing health checkups
by: Tatsuya Fukuda, et al.
Published: (2025-06-01)

INCIDENTAL HEPATIC STEATOSIS IDENTIFIED ON ULTRASOUND IN PATIENTS UNDERGOING CHOLECYSTECTOMY: HIGH PREVALENCE AND INSUFFICIENT INVESTIGATIVE AND CLINICAL MANAGEMENT
by: Heloísa Mello TRAPP, et al.
Published: (2025-05-01)

A hepatocellular carcinoma model with and without parenchymal liver damage that integrates technical and pathophysiological advantages for therapy testing
by: Karina Benderski, et al.
Published: (2025-01-01)

Liver TET1 promotes metabolic dysfunction-associated steatotic liver disease
by: Hongze Chen, et al.
Published: (2025-03-01)

Steatotic Liver Disease: New Nomenclature and Its Localization in the Russian Federation
by: K. L. Raikhelson, et al.
Published: (2024-05-01)

Laparoscopically confirmed endometriosis and the risk of incident NAFLD: a prospective cohort study
by: Hangkai Huang, et al.
Published: (2025-04-01)

Metabolic associated steatotic liver disease misses fewer high-risk patients than metabolic associated fatty liver disease
by: Yu-Ming Cheng, et al.
Published: (2024-12-01)

A prospective comparison of two ultrasound attenuation imaging modes using different frequencies for assessing hepatic steatosis
by: Hyeon Ji Jang, et al.
Published: (2025-05-01)

Current and Emerging Treatments for Metabolic Associated Steatotic Liver Disease and Diabetes: A Narrative Review
by: Rachelle Choi, et al.
Published: (2025-06-01)